|
"liu jp"的相關文件
顯示項目 1-25 / 74 (共3頁)
1 2 3 > >>
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2024 |
ADAM9 drives the immunosuppressive microenvironment by cholesterol biosynthesis-mediated activation of IL6-STAT3 signaling for lung tumor progression
|
Liu, JP;Shen, KY;Cheng, WC;Chang, WC;Hsieh, CY;Lo, CC;Kuo, TT;Lin, CC;Liu, SJ;Huang, WC;Sher, YP |
| 國家衛生研究院 |
2023-05-01 |
ADAM9 drives immunosuppressive environment for lung tumor progression
|
Sher, YP;Liu, JP;Liu, SJ |
| 國家衛生研究院 |
2020-01-06 |
Chchd2 regulates mitochondrial morphology by modulating the levels of Opa1
|
Liu, W;Duan, X;Xu, L;Shang, W;Zhao, J;Wang, L;Li, JC;Chen, CH;Liu, JP;Tong, C |
| 國家衛生研究院 |
2019-10 |
ADAM9 as a target for lung cancer treatment
|
Sher, YP;Liu, JP;Lo, CC;Kuo, TT;Liu, SJ |
| 國家衛生研究院 |
2016-11 |
Large-scale search method for locating and identifying fugitive emission sources in petrochemical processing areas
|
Yang, JC;Chang, PE;Chie, WC;Liu, JP;Wu, CF |
| 國家衛生研究院 |
2016-04-27 |
Addressing loss of efficiency due to misclassification error in enriched clinical trials for the evaluation of targeted therapies based on the Cox proportional hazards model
|
Tsai, CA;Lee, KT;Liu, JP |
| 國家衛生研究院 |
2015-06 |
Association of quality of life with laboratory measurements and lifestyle factors in community dwelling older people in Taiwan
|
Wu, TY;Chie, WC;Liu, JP;Liaw, CK;Netuveli, G;Blane, D |
| 國家衛生研究院 |
2014-10-13 |
Sample size determination for individual bioequivalence inference
|
Chiang, C;Hsiao, CF;Liu, JP |
| 國家衛生研究院 |
2014-09 |
An approximate approach to sample size determination in bioequivalence testing with multiple pharmacokinetic responses
|
Tsai, CA;Huang, CY;Liu, Jp |
| 國家衛生研究院 |
2014-03 |
Sample size determination for within-device precision
|
Chiang, C;Hsiao, CF;Liu, JP |
| 國家衛生研究院 |
2013-09 |
Quality of life (QOL) among community dwelling older people in Taiwan measured by the CASP-19, an index to capture QOL in old age
|
Wu, TY;Chie, WC;Kuo, KL;Wong, WK;Liu, JP;Chiu, ST;Cheng, YH;Netuveli, G;Blane, D |
| 國家衛生研究院 |
2013-07 |
Factors associated with falls among community-dwelling older people in Taiwan
|
Wu, TY;Chie, WC;Yang, RS;Liu, JP;Kuo, KL;Wong, WK;Liaw, CK |
| 國家衛生研究院 |
2013-05 |
Statistical inference on censored data for targeted clinical trials under enrichment design
|
Chen, CF;Lin, JR;Liu, JP |
| 國家衛生研究院 |
2013-05 |
An approximate approach to sampling size determination for the equivalence hypothesis
|
Hsieh, CY;Liu, JP |
| 國家衛生研究院 |
2013-02 |
Application of the parallel line assay to assessment of biosimilar products based on binary endpoints
|
Lin, JR;Chow, SC;Chang, CH;Lin, YC;Liu, Jp |
| 國家衛生研究院 |
2012-10 |
Statistical methods for bridging studies
|
Chow, SC;Chiang, C;Liu, JP;Hsiao, CF |
| 國家衛生研究院 |
2012-07-26 |
A bayesian approach for evaluation of bridging studies
|
Hsiao, CF;Tsou, HH;Liu, JP;Wu, YJ |
| 國家衛生研究院 |
2012-07-26 |
Two-stage designs of bridging studies
|
Hsiao, CF;Tsou, HH;Liu, JP;Wu, YJ |
| 國家衛生研究院 |
2012-07 |
Design and analysis of bridging studies
|
Hsiao, CF;Liu, JP;Chow, SC |
| 國家衛生研究院 |
2012-07 |
Authors' reply to the letter to the editor by L. Chen and Y. X. Liu.
|
Liu, JP;Lin, JR;Chow, SC |
| 國家衛生研究院 |
2012-01 |
An inferential procedure for the probability of passing the USP dissolution test
|
Chiang, C;Chen, CF;Huang, MY;Liu, JP |
| 國家衛生研究院 |
2011-11 |
Predicting healthcare utilization using a pharmacy-based metric with the WHO's anatomic therapeutic chemical algorithm
|
Kuo, RN;Dong, YH;Liu, JP;Chang, CH;Shau, WY;Lai, MS |
| 國家衛生研究院 |
2011-07 |
A consistency approach to evaluation of bridging studies and multiregional trials
|
Tsou, HH;Chien, TY;Liu, JP;Hsiao, CF |
| 國家衛生研究院 |
2011-04 |
Nationwide periodic health examinations promote early treatment of hypertension, diabetes and hyperlipidemia in adults: Experience from Taiwan
|
Lin, CC;Ko, CY;Liu, JP;Lee, YL;Chie, WC |
| 國家衛生研究院 |
2011-03 |
An alternative phase II/III design for continuous endpoints
|
Huang, WS;Liu, JP;Hsiao, CF |
顯示項目 1-25 / 74 (共3頁)
1 2 3 > >>
每頁顯示[10|25|50]項目
|
